About
Profile
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
BMRN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.02, revenue of $581.3M misses by $26.46M
- BioMarin appoints Alexander Hardy as president and chief executive officer
- BioMarin Pharmaceutical Q3 2023 Earnings Preview
- Bernstein upgrades BioMarin to market perform, citing valuation
- FDA approves use of BioMarin drug Voxzogo in children under 5
- BioMarin a market perform at Raymond James due to growth concerns
- BioMarin Pharmaceutical Non-GAAP EPS of $0.54 beats by $0.07, revenue of $595.3M in-line
- BioMarin Pharmaceutical Q2 2023 Earnings Preview
- BioMarin upgraded at BMO after FDA nod for hemophilia A therapy
- BioMarin granted FDA nod for hemophilia A gene therapy
- Eli Lilly, Humana among best health care names in defensive environment - BofA
- BioMarin Pharmaceutical Non-GAAP EPS of $0.60 beats by $0.20, revenue of $596.4M beats by $26.01M
- BioMarin Pharmaceutical Q1 2023 Earnings Preview
- What is behind biotech M&A resurgence?
- FDA to back accelerated approval pathway for gene therapies
- BioMarin seeks FDA nod to expand use of its Voxzogo treatment in children under five
- BioMarin's Roctavian gets FDA action date extended to end of June
- BridgeBio soars 55% after Phase 2 data for achondroplasia candidate
- BioMarin Pharmaceutical GAAP EPS of $0.00 beats by $0.07, revenue of $537.5M misses by $0.74M
- BioMarin Pharmaceutical Q4 2022 Earnings Preview
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
Oct 9, 2023 | 87.03 | 86.85 |
87.48
|
86.16
|
796K | -1.23% | ||||
Oct 6, 2023 | 88.11 | 87.06 |
89.05
|
86.97
|
890K | 0.94% | ||||
Oct 5, 2023 | 87.29 | 85.76 |
87.55
|
85.56
|
958K | 1.62% | ||||
Oct 4, 2023 | 85.9 | 86.33 |
86.56
|
85.14
|
899K | -0.34% | ||||
Oct 3, 2023 | 86.19 | 86.52 |
87.55
|
86.15
|
1.3M | -1.02% | ||||
Oct 2, 2023 | 87.08 | 88.35 |
88.35
|
85.86
|
1.7M | -1.58% | ||||
Sep 29, 2023 | 88.48 | 89.57 |
89.94
|
88.34
|
1.6M | -0.86% | ||||
Sep 28, 2023 | 89.25 | 89.54 |
90.15
|
88.43
|
1.6M | -1.24% | ||||
Sep 27, 2023 | 90.37 | 88.74 |
90.77
|
88.37
|
2.3M | 2.62% | ||||
Sep 26, 2023 | 88.06 | 87.17 |
88.55
|
86.9
|
2.2M | 1.17% | ||||
Sep 25, 2023 | 87.04 | 86.28 |
87.39
|
85.86
|
1.3M | 0.61% | ||||
Sep 22, 2023 | 86.51 | 86.28 |
86.99
|
85.76
|
977K | 0.28% | ||||
Sep 21, 2023 | 86.27 | 87.78 |
88.24
|
86.19
|
995K | -2.39% | ||||
Sep 20, 2023 | 88.38 | 88.72 |
89.66
|
87.98
|
919K | -0.5% | ||||
Sep 19, 2023 | 88.82 | 88.84 |
89.59
|
88.09
|
1.2M | 0.25% | ||||
Sep 18, 2023 | 88.6 | 88.07 |
88.79
|
87.91
|
1.0M | 0.50% | ||||
Sep 15, 2023 | 88.16 | 87.38 |
89.14
|
87.02
|
1.5M | 0.55% | ||||
Sep 14, 2023 | 87.68 | 91.99 |
92.48
|
87.6
|
1.4M | -4.3% | ||||
Sep 13, 2023 | 91.62 | 92.3 |
92.95
|
90.96
|
1.1M | -0.48% | ||||
Sep 12, 2023 | 92.06 | 91.2 |
92.28
|
90.7
|
728K | 1.32% | ||||
Sep 11, 2023 | 90.86 | 90.2 |
90.91
|
89.61
|
1.2M | 0.74% | ||||
Sep 8, 2023 | 90.19 | 90.81 |
91.38
|
89.85
|
949K | -0.25% | ||||
Sep 7, 2023 | 90.42 | 90.72 |
90.99
|
89.05
|
1.1M | -0.64% | ||||
Sep 6, 2023 | 91 | 90.35 |
91.48
|
90.29
|
1.2M | 0.29% | ||||
Sep 5, 2023 | 90.74 | 92.48 |
92.61
|
90.63
|
1.1M | -2.46% | ||||
Sep 1, 2023 | 93.03 | 92.21 |
93.73
|
91.54
|
1.0M | 1.81% | ||||
Aug 31, 2023 | 91.38 | 94.42 |
95.03
|
91.15
|
1.4M | -2.59% | ||||
Aug 30, 2023 | 93.81 | 95 |
95.13
|
93.52
|
920K | -0.71% | ||||
Aug 29, 2023 | 94.48 | 93.3 |
94.64
|
92.09
|
1.0M | 0.85% | ||||
Aug 28, 2023 | 93.68 | 94 |
94.39
|
92.85
|
1.3M | 0.04% | ||||
Aug 25, 2023 | 93.64 | 93.54 |
93.89
|
91.98
|
734K | 0.54% | ||||
Aug 24, 2023 | 93.14 | 91.35 |
93.27
|
91.04
|
1.1M | 2.27% | ||||
Aug 23, 2023 | 91.07 | 91.12 |
91.17
|
90.04
|
754K | 0.60% | ||||
Aug 22, 2023 | 90.53 | 89.94 |
90.86
|
89.79
|
485K | 0.73% | ||||
Aug 21, 2023 | 89.87 | 88.89 |
90.38
|
88.74
|
935K | 0.92% | ||||
Aug 18, 2023 | 89.05 | 89.27 |
90.16
|
88.46
|
1.2M | -0.39% | ||||
Aug 17, 2023 | 89.4 | 90 |
90.78
|
89.32
|
704K | -0.67% | ||||
Aug 16, 2023 | 90 | 90 |
90.73
|
89.45
|
660K | -0.74% | ||||
Aug 15, 2023 | 90.67 | 90.2 |
91.18
|
89.72
|
610K | 0.42% | ||||
Aug 14, 2023 | 90.29 | 89.29 |
90.77
|
89.01
|
776K | 0.98% | ||||
Aug 11, 2023 | 89.41 | 90.57 |
90.78
|
88.93
|
1.0M | -1.65% | ||||
Aug 10, 2023 | 90.91 | 93.21 |
93.4
|
89.78
|
1.3M | -2.49% | ||||
Aug 9, 2023 | 93.23 | 91.29 |
94.07
|
91.24
|
1.7M | 2.89% | ||||
Aug 8, 2023 | 90.61 | 88.29 |
90.88
|
87.93
|
1.4M | 3.17% | ||||
Aug 7, 2023 | 87.83 | 88.1 |
88.17
|
87.25
|
828K | -0.8% | ||||
Aug 4, 2023 | 88.54 | 87.88 |
89.43
|
87.88
|
1.1M | 0.91% | ||||
Aug 3, 2023 | 87.74 | 88.37 |
88.54
|
87.69
|
1.1M | -0.74% | ||||
Aug 2, 2023 | 88.39 | 88.85 |
89.62
|
87.13
|
1.1M | -0.69% | ||||
Aug 1, 2023 | 89 | 87 |
89.08
|
84.65
|
3.2M | 1.22% | ||||
Jul 31, 2023 | 87.93 | 87.94 |
88.05
|
87.07
|
1.5M | 0.37% | ||||
Jul 28, 2023 | 87.61 | 87.31 |
87.72
|
86.25
|
1.2M | 1.21% | ||||
Jul 27, 2023 | 86.56 | 87.77 |
87.78
|
86.06
|
1.2M | -0.81% | ||||
Jul 26, 2023 | 87.27 | 87.65 |
88.05
|
86.91
|
951K | -0.64% | ||||
Jul 25, 2023 | 87.83 | 87.54 |
88.17
|
87.46
|
876K | 0.48% | ||||
Jul 24, 2023 | 87.41 | 87.58 |
88.58
|
87.34
|
854K | -0.35% | ||||
Jul 21, 2023 | 87.72 | 87.91 |
88.3
|
87.38
|
1.2M | 0.21% | ||||
Jul 20, 2023 | 87.54 | 86.91 |
87.89
|
86.63
|
845K | 0.53% | ||||
Jul 19, 2023 | 87.08 | 86.93 |
87.6
|
86.33
|
960K | 0.93% | ||||
Jul 18, 2023 | 86.28 | 86.66 |
87.08
|
85.66
|
1.2M | -0.45% | ||||
Jul 17, 2023 | 86.67 | 85.87 |
87.36
|
85.5
|
960K | 0% |